Why is Suven Life Scie. falling/rising?

As of 25-Jul, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 281.40, which represents a decrease of Rs 7.1 or 2.46%. The stock has underperformed its sector today by 2.63% and opened with a loss of 2.08%. It reached an intraday low of Rs 272.25, reflecting a significant drop of 5.63%. Despite a strong long-term performance, with a 99.29% return over the past year, the company is facing challenges such as operating losses and a weak long-term fundamental strength, with net sales declining at an annual rate of 49.94% and negative EBITDA. Additionally, the company has reported negative results for the last three consecutive quarters, which has contributed to the recent price movement.
In the broader market context, the stock's short-term performance has been notably worse than the benchmark, with a 1-week return of -2.46% compared to the Sensex's -0.36%. This underperformance is compounded by falling participation from institutional investors, who have reduced their stake by 1.13% in the last quarter, indicating a lack of confidence in the company's fundamentals. The stock's liquidity remains adequate, but the overall sentiment is affected by the company's weak financial indicators and declining investor interest, which are likely driving the stock's current downward trend.